{"id":"normal-dose-acetazolamide","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Normal Dose Acetazolamide","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:59:29.400295+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:59:34.897876+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Normal Dose Acetazolamide","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:59:35.200995+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Carbonic anhydrase IV inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:59:36.238846+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL20/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:59:35.905897+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-27T23:57:43.775Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:59:37.456181+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT05707442","phase":"PHASE3","title":"Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-16","conditions":"Idiopathic Intracranial Hypotension, Venous Sinus Stenosis","enrollment":74},{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT05411991","phase":"PHASE4","title":"Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment","status":"COMPLETED","sponsor":"Vrije Universiteit Brussel","startDate":"2022-06-12","conditions":"Acute Heart Failure, Diuretics Drug Reactions","enrollment":107},{"nctId":"NCT04975269","phase":"PHASE2","title":"Acetazolamide Trial in Normal Pressure Hydrocephalus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Uppsala University Hospital","startDate":"2022-02-17","conditions":"Idiopathic Normal Pressure Hydrocephalus (INPH)","enrollment":50},{"nctId":"NCT04470843","phase":"PHASE1","title":"Impact of Acetazolamide in Reducing Referred Postoperative Pain","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2018-08-22","conditions":"Prostate Cancer, Men","enrollment":33},{"nctId":"NCT03490916","phase":"PHASE4","title":"Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography","status":"TERMINATED","sponsor":"Vincent Kan","startDate":"2018-03-23","conditions":"High Altitude Pulmonary Edema","enrollment":18},{"nctId":"NCT01993667","phase":"PHASE4","title":"Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing","status":"COMPLETED","sponsor":"University of Utah","startDate":"2012-03","conditions":"Prophylaxis of Acute Mountain Sickness","enrollment":130},{"nctId":"NCT01923454","phase":"NA","title":"Immediate Anterior Chamber Paracentesis With A 30-Gauge Needle for Acute Primary Angle - Closure","status":"COMPLETED","sponsor":"Siriraj Hospital","startDate":"2005-12","conditions":"Glaucoma, Angle-closure","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL20"},"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Diamox"],"phase":"marketed","status":"active","brandName":"Normal Dose Acetazolamide","genericName":"Normal Dose Acetazolamide","companyName":"University of Utah","companyId":"university-of-utah","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:59:37.456181+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}